(Q28217274)

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Human distribution and release of a putative new gut hormone, peptide YY

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Structure-activity studies including a Psi(CH(2)-NH) scan of peptide YY (PYY) active site, PYY(22-36), for interaction with rat intestinal PYY receptors: development of analogues with potent in vivo activity in the intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY augments postprandial small intestinal absorption in the conscious dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Growth-regulatory effects of sensory neuropeptides, epidermal growth factor, insulin, and somatostatin on the non-transformed intestinal epithelial cell line IEC-6 and the colon cancer cell line HT 29.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Preservation of intestine protein by peptide YY during total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrition and treated with peptide YY and clenbuterol

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Colonic endocrine cells in patients with carcinoma of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

How age changes the content of neuroendocrine peptides in the murine gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Effects of gastrointestinal peptides on azoxymethane-treated colonic mucosa in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration. A proliferative role for PYY in the intestinal epithelium?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Is peptide YY trophic to the intestinal epithelium of parenterally fed rats?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY inhibits growth of human breast cancer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Effects of peptide YY on the growth of the pancreas and intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Immunohistochemical analysis of gastrointestinal carcinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY augments gross inhibition by vitamin E succinate of human pancreatic cancer cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Immunohistochemical and ultrastructural studies of twelve argentaffin and six argyrophil carcinoids of the appendix vermiformis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY immunoreactive cells in gastrointestinal carcinoids: immunohistochemical and ultrastructural studies of 60 tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Neuroendocrine cells within colorectal tumours induced by dimethylhydrazine. An immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Intraluminal peptide YY induces colonic absorption in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Adjuvant hormonal treatment with peptide YY or its analog decreases human pancreatic carcinoma growth

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY/neuropeptide Y Y1 receptor expression in the epithelium and mucosal nerves of the human colon

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Nutrition in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY (PYY), a potent orexigenic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Functioning ovarian carcinoids induce severe constipation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Effects of keratinocyte growth factor (KGF) on gut growth and repair

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Neuropeptide Y and peptide YY stimulate the growth of exocrine pancreatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY selectively stimulates expression of the colonocytic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Ovarian strumal carcinoid with severe constipation: immunohistochemical and mRNA analyses of peptide YY

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Peptide YY-like immunoreactivity in normal colon mucosa, muscle layer and adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Role of peptide YY in the endocrine control of digestion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Polypeptide YY (PYY) and pancreatic polypeptide (PP) in rectal carcinoids. An immunocytochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021

Ovarian carcinoid with severe constipation due to peptide YY production

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2801%2900616-7

7 January 2021